CBER Reports
CBER Reports are a summary of regulatory, research, and administrative accomplishments for the last 2 fiscal years and related reports.
Sub-Topic Paragraphs
General
![Photo of Peter Marks, M.D, Ph.D.](/files/styles/medium_3/public/peter_marks_19929.jpg?itok=WtAelH5u)
CY 2024 Report from the Director
![U.S. Capitol](/files/styles/medium_3/public/us-capital.jpg?itok=u2dvFwbk)
FDA Report to Congress: Least Burdensome Training Audit
![U.S. Capitol with keyboard graphic overlay](/files/styles/medium_3/public/us-capitol2.jpg?itok=gcAEtM7g)
FDA Report to Congress: Least Burdensome Training Audit Addendum
![person holding medical test tube](/files/styles/medium_3/public/medical_test_tube.jpg?itok=GkDFS6Ht)
User Fee Billable Biologic Products and Potencies Approved Under Section 351 of…
![Cropped shot of a man reading the label on a box of medicine in a pharmacy](/files/styles/medium_3/public/medication_label.jpg?itok=GRBX3Rdx)
Biologics PREA Reviews and Labeling Changes
![Electronic document management system concept, searching and business managing files online document database, efficient archiving and company information datum.](/files/styles/medium_3/public/laptop.jpg?itok=ThCx4wDY)